Transitioning from basal–bolus or premix insulin therapy to a combination of basal insulin and glucagon‐like peptide‐1 receptor agonist in people with type 2 diabetes-Reference-Cited by-同舟云学术

Transitioning from basal–bolus or premix insulin therapy to a combination of basal insulin and glucagon‐like peptide‐1 receptor agonist in people with type 2 diabetes

Published:2022-06-26 Issue:9 Volume:39 Page:
ISSN:0742-3071
Container-title:Diabetic Medicine
language:en
Short-container-title:Diabet Med

Author:

Mehta Roopa¹,Billings Liana K.²³^ORCID,Liebl Andreas⁴,Vilsbøll Tina⁵

Affiliation:

1. Unidad de Investigación en Enfermedades Metabólicas, Departamento de Endocrinología y Metabolismo Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán Mexico City Mexico

2. Division of Endocrinology and Metabolism NorthShore University HealthSystem Skokie Illinois USA

3. Department of Medicine University of Chicago Pritzker School of Medicine Skokie Illinois USA

4. Center for Diabetes and Metabolism, m&i‐Fachklinik Bad Heilbrunn Germany

5. Steno Diabetes Center Copenhagen, Gentofte Hospital Gentofte Denmark

Funder

Novo Nordisk

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dme.14901

Reference52 articles.

1. Intensifying Insulin Therapy: What Options Are Available to Patients with Type 2 Diabetes?

2. 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes—2022

3. Efficacy of Insulin Analogs in Achieving the Hemoglobin A1c Target of <7% in Type 2 Diabetes

4. Intensification of Insulin Therapy for Type 2 Diabetic Patients in Primary Care: Basal-Bolus Regimen Versus Premix Insulin Analogs

5. Clinical Considerations When Initiating and Titrating Insulin Degludec/Liraglutide (IDegLira) in People with Type 2 Diabetes

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tirzepatide Improved Health-Related Quality of Life Compared with Insulin Lispro in Basal Insulin-Treated Adults with Type 2 Diabetes and Inadequate Glycaemic Control: A Randomised Controlled Phase 3b Trial (SURPASS-6);Diabetes Therapy;2024-07-15

2. Therapy of Type 2 Diabetes;Experimental and Clinical Endocrinology & Diabetes;2024-04-10

3. Therapie des Typ-2-Diabetes;Die Diabetologie;2024-01-30

4. Therapie des Typ-2-Diabetes;Diabetologie und Stoffwechsel;2023-10

5. Issues of insulin therapy for type 2 diabetes and ways to solve them;INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine);2023-06-01